Infants have long been known to have higher infectious diseases morbidity and mortality and suboptimal vaccination responses compared to older children and adults. A variety of differences in innate and adaptive immune responses have been described between these two groups. We compared Toll-like receptor (TLR)-induced production of pro-interleukin (IL)-1b, IL-6, and tumor necrosis factor (TNF)-a between 2-month-old infants and adults. TLR 7/8-induced production of pro-IL1b and IL-6 in monocytes was lower in 2-month-old infants compared to adults. There was no difference in TLR 7/8-induced production of TNF-a. Lower TLR-induced production of pro-IL-1b and IL-6 in innate immune cells during early infancy likely contributes to suboptimal vaccine responses and infectious diseases susceptibility. 
Introduction
Infants have long been known to have higher infectious diseases morbidity and mortality compared to older children and adults. They also have suboptimal vaccination responses to many antigens. One contributing factor has been felt to be differences in the immune responses between infants and older children/ adults. A variety of differences in innate and adaptive immune responses have been described between these two groups. The fetal and early neonatal immune system is heavily T-helper 2 (Th2) biased [1, 2] . Toll-like receptor (TLR) responses known to induce Th17 adaptive immune responses peaked at birth and subsequently declined over the next 2 years. TLR responses known to induce anti-viral and Th1 adaptive immune responses were low at birth and slowly increased over the next 2 years [3] . We compared TLR-induced production of pro-interleukin (IL)-1b, IL-6, and tumor necrosis factor (TNF)-a between 2 month old infants and adults. TLR 7/8-induced production of pro-IL-1b and IL-6 in monocytes was lower in 2 month old infants compared to adults.
Materials and Methods

Ethics statement
The infant clinical study was approved by the institutional review boards of the Research Institute for Tropical Medicine, Philippines, and the University of Massachusetts Medical School.
Mothers and their healthy infants were recruited and enrolled after providing written informed consent.
Peripheral blood mononuclear cells (PBMC) from healthy adult volunteers were collected and isolated using HistopaqueH density centrifugation, and cryopreserved. The protocol was approved by the institutional review board of the University of Massachusetts Medical School. Adult volunteers were recruited and enrolled after providing written informed consent.
Infant clinical study
Details about the infant clinical study protocol have been previously described [4] . Study enrollment began in October 2006 in San Pablo, Philippines. The clinical study is registered at www. clinicaltrials.gov (identifier NCT00377754). Healthy infants and their mothers were enrolled when the infant was between 6-18 weeks old. Peripheral blood mononuclear cells (PBMC) were collected from infants at the first study visit, isolated using HistopaqueH density centrifugation, and cryopreserved. Clinical and epidemiological information were also collected at the study visits. Infant weight was measured to the nearest tenth of a kilogram. Infant length was measured to the nearest centimeter. World Health Organization (WHO) body mass index (BMI)-forage z scores for study infants were determined using the SPSS macro provided by WHO [5] . Infants with missing values or biologically implausible anthropometric z scores were excluded from analyses. Biologically implausible z scores were BMI-for-age z score ,26 or .6. TNF-a, IL-6, and pro-IL-1b production was measured by staining with the respective mAbs (anti-TNF-a-PerCP.Cy5.5, anti-IL-6-Alexa700, anti-IL-1b-PacBlue, BD Biosciences). Cells were analyzed using a FACSAria TM flow cytometer (BD Biosciences). Data was analyzed using FlowJoH software (Treestar). 
Statistical analysis
The SPSS software package (version 20.0) was used for statistical analyses. Comparisons between continuous variables were performed using the non-parametric Mann-Whitney U test. P-values ,0.05 were considered significant.
Results and Discussion
As part of a prospective study of dengue virus infections during infancy [4] , we stimulated PBMC from healthy infants and adults with R-848 and measured intracellular pro-IL-1b, IL-6, and TNFa by FACS. R-848 is an imidazoquinolone and stimulates human TLR 7/8 [6] . We found that TLR 7/8-induced pro-IL-1b and IL-6 production in monocytes was lower in 2 month old healthy infants (n = 25) compared to healthy adults (n = 7) (Figure 1) . TLR 7/8-induced TNF-a production in monocytes was not different between the two groups. The monocyte gating strategy is shown in Figure 2 . Natural killer (NK) cell markers were not utilized and could potentially contaminate the monocyte gate. The vast majority of the infants were well nourished and had a WHO BMI-for-age z score $22 (21/25 (84%)). R-848-induced pro-IL1b production also trended lower in the circulating myeloid dendritic cells (mDCs) from 2 month old infants compared to adults (% pro-IL-1b+ mDCs upon R-848 (1 mM) stimulation (unstimulated background subtracted): infants (n = 33)210.9 [4.9-14.8], adults (n = 5)219.6 [11.0-27.9], median [95% CI], p = 0.07). R-848-induced IL-6 and TNF-a production in mDCs was not different between infants and adults (data not shown).
In a previous report, pro-IL-1b and IL-6 production in cord blood mononuclear cells upon stimulation with 3M-003, another imidazoquinolone, was similar to adult mononuclear cells and then decreased at 1 and 2 years of age [3] . Our data demonstrates that as early as 2 months of age, TLR 7/8-induced pro-IL-1b and IL-6 production in monocytes is lower than adult responses. The lower TLR-induced production of pro-IL-1b and IL-6 in innate immune cells during early infancy likely contributes to their suboptimal vaccine responses and infectious diseases susceptibility.
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